Attached files

file filename
10-K - ANNUAL REPORT - OptimizeRx Corpf10k2019_optimizerxcorp.htm
EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO - OptimizeRx Corpf10k2019ex32-1_optimizerx.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECURITIES EXCHANGE ACT RUL - OptimizeRx Corpf10k2019ex31-2_optimizerx.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECURITIES EXCHANGE ACT RUL - OptimizeRx Corpf10k2019ex31-1_optimizerx.htm
EX-23.1 - CONSENT OF MARCUM LLP - OptimizeRx Corpf10k2019ex23-1_optimizerx.htm
EX-21.1 - LIST OF SUBSIDIARIES - OptimizeRx Corpf10k2019ex21-1_optimizerx.htm
EX-10.6 - AMENDMENT TO EMPLOYMENT AGREEMENT WITH MIRIAM PARAMORE, DATED MARCH, 10, 2020 - OptimizeRx Corpf10k2019ex10-6_optimizerx.htm
EX-10.5 - AMENDMENT TO EMPLOYMENT AGREEMENT WITH STEPHEN SILVESTRO, DATED MARCH, 10, 2020 - OptimizeRx Corpf10k2019ex10-5_optimizerx.htm
EX-10.4 - AMENDMENT TO EMPLOYMENT AGREEMENT WITH WILLIAM FEBBO, DATED MARCH, 10, 2020 - OptimizeRx Corpf10k2019ex10-4_optimizerx.htm

Exhibit 10.3

 

Employment Agreement Addendum I

Addendum to agreement dated February 17, 2019

 

This first addendum to the employment agreement (the “Addendum”) is made this 10th day of March 2020, by and between OptimizeRx, Corporation (the “Company”), a Nevada Company, and Douglas Baker (the “Executive”).

 

Base Salary: The Executive will receive a base salary at the annualized rate of $260,000.00 (“Base Salary”), which will be paid in accordance with normal Company payroll practices and subject to the usual and applicable required withholding(s).

 

Effective Date: January 1, 2020

 

Acknowledgment:

 

Except as expressly set forth herein, all other terms of the Agreement remain in full force and effect.

 

OptimizeRx, Corporation   Douglas Baker
     
By: Will Febbo   By: Douglas P. Baker
Its: Chief Executive Officer   Date: March 10, 2020
Date: March 10, 2020